Inogen (INGN) EBIT Growth (3y) (2016 - 2026)
Inogen (INGN) EBIT Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 3.16% |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 19.80% |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 31.84% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 24.88% |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 35.44% |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 9.04% |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 60.19% |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 13.06% |
| 10 | Inogen | 152.53 Mn | 47.00 Mn | 43.27 Mn | 24.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.34% |
| Mar 31, 2026 | 24.76% |
| Dec 31, 2025 | 45.81% |
| Sep 30, 2025 | 11.57% |
| Jun 30, 2025 | -28.69% |
| Mar 31, 2025 | 17.40% |
| Dec 31, 2024 | -19.50% |
| Sep 30, 2024 | -47.71% |
| Jun 30, 2024 | -37.60% |
| Mar 31, 2024 | -96.90% |
| Dec 31, 2023 | -73.78% |
| Sep 30, 2023 | -187.16% |
| Jun 30, 2023 | -71.06% |
| Mar 31, 2023 | -115.85% |
| Dec 31, 2022 | -122.34% |
| Sep 30, 2022 | -48.42% |
| Jun 30, 2022 | -30.78% |
| Mar 31, 2022 | -68.65% |
| Dec 31, 2021 | -50.33% |
| Sep 30, 2021 | -15.05% |